Skip to main content

STIFEL FINANCIAL CORP

Position in TCRX — TScan Therapeutics, Inc.

CIK 720672 ST. LOUIS, MO

Position in TCRX

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$70,094
-$2,306 QoQ
Shares Held
69,400
-4.1% QoQ
Ownership
0.106%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2023
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TCRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

STIFEL FINANCIAL CORP holds $431,497,751 across 103 Biotechnology names. TCRX ranks #94 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in TCRX

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $70,094 69,400
2025-12-31 $72,400 72,400
2025-09-30 $177,268 97,400
2025-06-30 $168,114 115,941
2025-03-31 $160,703 116,452
2024-12-31 $333,488 109,700
2024-09-30 $493,682 99,133
2024-06-30 $558,090 95,400
2024-03-31 $805,116 101,400
2023-12-31 $701,932 120,400
2023-09-30 $299,264 116,900
2023-06-30 $247,500 99,000